Q-linea AB (publ) (QLINEA) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Q-linea Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.818 Hello and welcome everyone to our presentation of our Q1 report. 00:00:04.818 -- 00:00:09.424 I know that we're going into a long weekend here in Sweden, so I really appreciate everyone 00:00:09.424 -- 00:00:12.689 taking the time to join. I'll 00:00:12.689 -- 00:00:17.696 start off with the usual disclaimer here. We'll take this as read and 00:00:17.696 -- 00:00:19.201 understood. 00:00:19.201 -- 00:00:23.709 So we'll go through the fairly regular agenda we've done on these. 00:00:23.709 -- 00:00:26.654 I'll give you some of the commercial updates here. 00:00:26.654 -- 00:00:31.684 I'll speak to our recent FDA clearance and what that means for us in the market and for 00:00:31.684 -- 00:00:35.951 our customers. And then I'll spend a little bit of time on our priorities for the remainder 00:00:35.951 -- 00:00:41.321 of the year before handing over to Krister to go through the financials and obviously 00:00:41.321 -- 00:00:44.564 the Q&A at the end. 00:00:44.564 -- 00:00:49.234 So with that, and for those who don't have very much time with us today, some highlight 00:00:49.234 -- 00:00:52.741 messages I would want you to take away from this presentation. 00:00:52.741 -- 00:00:58.313 The first point is that Q1 of this year was thus far a record one for 00:00:58.313 -- 00:01:02.502 moving instruments into the market. We put seven instruments out there. 00:01:02.502 -- 00:01:08.167 I'll talk more to that. We also saw our highest demand yet for consumables. 00:01:08.329 -- 00:01:13.516 This is notwithstanding an approval that came during April for the FDA 00:01:13.516 -- 00:01:17.862 clearance. So this is our big news for this month. 00:01:17.862 -- 00:01:21.226 It materially expands our value proposition for U.S. 00:01:21.226 -- 00:01:...